Turnstone Biologics Corp. Assets, Fair Value Disclosure
Turnstone Biologics Corp. had Assets, Fair Value Disclosure of $16.46 million as of 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Notes
us-gaap:AssetsFairValueDisclosure · last filed 2025-08-08
- 2025-06-30: Assets, Fair Value Disclosure $16.46M.
- 2025-03-31: Assets, Fair Value Disclosure $17.99M.
- 2024-12-31: Assets, Fair Value Disclosure $22.27M.
- 2024-09-30: Assets, Fair Value Disclosure $37.37M.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2025-06-30 | $16.46M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $17.99M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $22.27M 10-Q · filed 2025-08-08 |
| 2024-09-30 | $37.37M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $52.24M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $75.64M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $92.73M 10-K · filed 2025-03-31 |
| 2023-09-30 | $105.35M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $44.36M 10-Q · filed 2023-09-01 |
| 2022-12-31 | $56.95M 10-K · filed 2024-03-22 |